NCT05809219

Brief Summary

Objective: To assess the effect of different post-exercise oral nutritional supplement intake timing on sarcopenia indicators in hemodialysis patients. Study Design: 24-weeks Randomized Control Trial (RCT), includes 12-wk intervention period and 12-week follow up period. Setting \& Participants: Maintenance hemodialysis patients who were older than 20 years old meet sarcopenia diagnosis criteria. Intervention: Group A: During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise. Participants take oral supplement in 1 to 2 hours after exercise program. Group B: Participants have the same exercise program and oral supplement as Group A. However, they take oral supplement in 2.5-4 hours after exercise program. Group C: Participants only take oral supplement. Control group: Participants maintain usual diet and physical activity without any intervention.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 12, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

July 10, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 29, 2024

Completed
Last Updated

September 22, 2023

Status Verified

September 1, 2023

Enrollment Period

8 months

First QC Date

March 18, 2023

Last Update Submit

September 21, 2023

Conditions

Outcome Measures

Primary Outcomes (6)

  • Appendicular skeletal muscle mass

    The weight of appendicular skeletal muscle mass. This is one of the sarcopenia indicator.

    Change from baseline appendicular skeletal muscle mass at 3 months

  • Appendicular skeletal muscle mass

    The weight of appendicular skeletal muscle mass. This is one of the sarcopenia indicator.

    Change from baseline appendicular skeletal muscle mass at 6 months

  • Muscle strength

    The measurement of handgrip strength. This is one of the sarcopenia indicator.

    Change from baseline muscle strength at 3 months

  • Muscle strength

    The measurement of handgrip strength. This is one of the sarcopenia indicator.

    Change from baseline muscle strength at 6 months

  • Physical performance

    Measuring whether the of 6-meter walk is less than 1.0 m/s or not. This is one of the sarcopenia indicator.

    Change from baseline physical performance at 3 months

  • Physical performance

    Measuring whether the of 6-metre walk is less than 1.0 m/s or not. This is one of the sarcopenia indicator.

    Change from baseline physical performance at 6 months

Study Arms (4)

Control group

NO INTERVENTION

Participants maintain usual diet and physical activity without any intervention

1 hour combined intervention ( Exercise and nutrition)

EXPERIMENTAL

During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise. Participants take oral supplement (103 kcal and 8.4 g of protein) in 1 to 2 hours after exercise program.

Other: 1 hour combined intervention ( Exercise and nutrition)

3 hours combined intervention ( Exercise and nutrition)

EXPERIMENTAL

The only one different between "1 hour combined intervention" and this intervention is the time interval between exercise and nutrition. The time interval of "1 hour combined intervention" is 1 to 2 hour, and this intervention is 2.5-4 hours. Other procedure is totally the same.

Other: 3 hours combined intervention ( Exercise and nutrition)

Nutrition intervention

EXPERIMENTAL

Participants only take oral supplement. The oral supplement is the same as the "1 hour combined intervention" and "3 hours combined intervention".

Dietary Supplement: Nutrition intervention

Interventions

Subjects take oral supplement after exercise in the time period between 1-2 hours. They will take oral supplement during hemodialysis treatment.

1 hour combined intervention ( Exercise and nutrition)

All procedures between "1 hour combined intervention" and "3 hours combined intervention" are the same. The only one different is the time interval between exercise and nutrition. In this arm, the time interval of exercise and nutrition is 2.5 to 4 hours. When we recruiting subjects, all interventions will be clearly introduced to them, including the same and the different parts among them.

3 hours combined intervention ( Exercise and nutrition)
Nutrition interventionDIETARY_SUPPLEMENT

Subjects only take oral supplement during hemodialysis treatment. The oral supplement is the same as the "1 hour combined intervention" and "3 hours combined intervention".

Nutrition intervention

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hemodialysis treatment longer than 3 months
  • Hemodialysis treatment 3 times treatment per weeks
  • Kt/V≥1.2 or URR≥65%
  • Taking foods by oral
  • Meeting the criteria of sarcopenia.

You may not qualify if:

  • Soy allergy
  • Amputation
  • Significantly edema
  • Receiving palliative care
  • Severe angina
  • Unstable arrhythmias
  • Severe infection
  • Heart failure (class 4 of New York Heart Association scale)
  • Central venous catheter or femoral arteriovenous fistula
  • Pacemaker
  • Pregnancy
  • Severe paleness
  • Severe difficulty breathing
  • Chest pain
  • Hospitalization 3 months before recruited in this study
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, 404327, Taiwan

Location

MeSH Terms

Conditions

Sarcopenia

Interventions

ExerciseNutritional StatusDiet Therapy

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaHealth StatusDemographyPopulation CharacteristicsNutrition TherapyTherapeutics

Study Officials

  • PEIYU WU

    Project Assistant Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Project Assistant Professor

Study Record Dates

First Submitted

March 18, 2023

First Posted

April 12, 2023

Study Start

July 10, 2023

Primary Completion

February 29, 2024

Study Completion

February 29, 2024

Last Updated

September 22, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

According to the records approved by IRB, the individual participant data of all participants should be protected.

Locations